Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Top ETF Areas For 2020

Published 12/24/2019, 11:26 PM
Updated 07/09/2023, 06:31 AM

Exchange traded funds have been basking in the glory during 2019 with their total assets under management amounting to nearly $4.3 trillion by November-end (per ETF.com data). Although the ongoing year has seen decelerating global economic growth, depleting export levels, relaxing monetary policies and most importantly, the twists and turns in the Sino-US trade war, the investment scenario for 2020 looks attractive. The IMF expects global growth at 3.4% next year compared with its forecast of 3% for 2019.

Certain positive developments raised investors’ optimism about a solution to the trade tussle. Meanwhile, the upbeat jobs and encouraging manufacturing updates are hinting at a healthier economy. The bullish U.S. homebuilders sentiment data for December also cheered investors. In fact, all three major U.S. bourses are scaling new highs. The broader market rally should not show any signs of slowing down, at least in early next year (read: ETF Strategies to Ride the Wall Street Bull Run).

Here are some ETF areas that can be good investor choices for 2020.

Emerging Market ETFs

Emerging markets are increasingly gaining popularity among investors. These markets are believed to have added wealth of about $11 trillion to investor portfolios over the past decade. In fact, a Bloomberg’s survey of 57 global investors, strategists and traders discussing their viewpoint for 2020 reported that developing-nation assets are expected to outperform their developed counterparts. Currently, total investment in emerging-market stocks and bonds surpasses $25 trillion, exceeding the combined economies of the United States and Germany.

The Sino-U.S. trade war is expected to be a major driver of emerging market investments in 2020, followed by China’s growth projection. Although currently all major global banks are keeping interest rates steady, their easier monetary policies earlier lent a huge support to the emerging markets. Investors can consider Vanguard FTSE Emerging Markets ETF VWO, iShares Core MSCI Emerging Markets ETF IEMG, iShares MSCI Emerging Markets ETF (NYSE:EEM) EEM and Schwab Emerging Markets Equity ETF (NS:SCHE) (read: Emerging Market ETFs Beating the Broader Market: Here's How).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Alternative Energy ETFs

Alternative energy includes any energy source that acts as a replacement to conventional and non-renewable fossil fuel. Going by an International Energy Agency (IEA) report, worldwide supplies of renewable electricity are estimated to expand 50% within five years. Moreover, according to the IEA, renewable energy sources are anticipated to make up 30% of the world’s electricity by 2024 in comparison to the current 26%.

Demand for energy sources is predicted to rise over time. Per an IEA report, energy demand is envisioned to inch up 1% annually through 2040. It further added that 50% of the surplus energy demand will be met by renewables with solar power becoming the most favorable source by 2040. Against this backdrop, investors can take a glance at Invesco Solar ETF (LON:TAN) , iShares Global Clean Energy ETF (NYSE:XLE) ICLN, Invesco Cleantech ETF PZD, First Trust NASDAQ Clean Edge Green Energy Index Fund QCLN and ALPS Clean Energy ETF ACES (read: Top-Performing Alternative Energy ETFs YTD).

Biotech ETFs

Ramped-up mergers and acquisition (M&A) deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market. The sector has been benefiting from a flurry of positive news including trial results and deal activities. M&As are leading the sector as sluggishness in mature products forced companies to explore buyouts to bolster their pipelines. Several other large-cap pharma and bigger biotech companies are inking collaboration deals with smaller ones to boost their pipeline. Thus, investors seeking to gain traction from the strengthening biotechnology market can take a look at iSharesNasdaq Biotechnology ETF IBB, SPDR S&P Biotech (NYSE:XBI) ETF XBI, First Trust Amex Biotechnology Index FBT, ARK Genomic Revolution Multi-Sector ETF (ARKG) and VanEck Vectors Biotech ETF (LON:BBH) (read: A Guide to Biotech ETF Investing).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Metal ETF

Palladium grabbed investor attention on its consistent rally in the ongoing year. The auto-catalyst metal just touched an all-time high of $2000 per ounce. The recent shutdown of palladium mines due to power crisis in South Africa, the world’s second-largest palladium supplier, has been pushing up prices higher. Palladium has been seeing solid demand for industrial products. The metal is used for catalytic converters in gasoline-powered cars. Meanwhile, the markets have been grappling with a supply crunch of palladium for long. Nonetheless, investors can check out Aberdeen Standard Physical Palladium Shares ETF PALL (read: Why Palladium ETF Has Soared in 2019).

Homebuilder ETFs

After three rate cuts in 2019, the Fed hinted at keeping interest rates intact in 2020 unless there is any major change in the economic outlook. It is widely believed that declining mortgage rates cushioned the housing sector as lower borrowing costs are making new houses more affordable. In fact, mortgage rates are currently at a low per historical standards. Per Freddie Mac, the average rate on a 30-year, fixed-rate mortgage was 3.73% as of Dec 12 and compares favorably with 4.94% in November 2018. Against the aforementioned backdrop, let’s take a look at some homebuilder ETFs like iShares U.S. Home Construction ETF (WA:ITB) , SPDR S&P Homebuilders (NYSE:XHB) ETF XHB and Invesco Dynamic Building & Construction ETF PKB.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


SPDR S&P Homebuilders ETF (XHB): ETF Research Reports

SPDR S&P Biotech ETF (XBI): ETF Research Reports

Vanguard FTSE Emerging Markets ETF (VWO): ETF Research Reports

iShares Nasdaq Biotechnology ETF (IBB): ETF Research Reports

First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN): ETF Research Reports

Schwab Emerging Markets Equity ETF (SCHE): ETF Research Reports

VanEck Vectors Biotech ETF (BBH): ETF Research Reports

Aberdeen Standard Physical Palladium Shares ETF (PALL): ETF Research Reports

iShares U.S. Home Construction ETF (ITB): ETF Research Reports

Invesco Dynamic Building & Construction ETF (PKB): ETF Research Reports

First Trust NYSE Arca Biotechnology Index Fund (FBT): ETF Research Reports

iShares Global Clean Energy ETF (ICLN): ETF Research Reports

Invesco Solar ETF (TAN): ETF Research Reports

iShares MSCI Emerging Markets ETF (EEM): ETF Research Reports

Invesco Cleantech ETF (PZD): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

can you trust Zacks
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.